Pharmacotherapy of posttraumatic stress disorder: Treatment options, long-term follow-up, and predictors of outcome

Journal of Clinical Psychiatry

Volumn 61, Issue SUPPL. 5, 2000, Pages

  Davidson, Jonathan R T ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; MONOAMINE OXIDASE INHIBITOR; SEROTONIN 2 ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

CLINICAL TRIAL; COMORBIDITY; CONFERENCE PAPER; DRUG EFFICACY; HUMAN; META ANALYSIS; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; SOCIAL STATUS; TREATMENT OUTCOME;

ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CLINICAL TRIALS; FLUOXETINE; FOLLOW-UP STUDIES; HUMANS; MONOAMINE OXIDASE INHIBITORS; PAROXETINE; SEROTONIN ANTAGONISTS; SEROTONIN UPTAKE INHIBITORS; STRESS DISORDERS, POST-TRAUMATIC; TREATMENT OUTCOME; TRIAZOLES;

EID: 0343776950     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (25)

1. Davidson JRT, Hughes D, Blazer DG, et al. Posttraumatic stress disorder in the community: an epidemiological study. Psychol Med 1991;21:713-721
2. Kessler RC, Sonnega A, Bromet E, et al. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry 1995;52:1048-1060
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Third Edition. Washington, DC: American Psychiatric Association: 1980
4. Shalev AY. Measuring outcome in posttraumatic stress disorder. J Clin Psychiatry 2000;61(suppl 5):33-39
5. Davidson J, Kudler H, Smith R, et al. Treatment of posttraumatic stress disorder with amitriptyline and placebo. Arch Gen Psychiatry 1990;47: 259-266
6. Kosten TR, Frank JB, Dan E, et al. Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine. J Nerv Ment Dis 1991;179: 366-370
7. Baker DG, Diamond BI, Gilette G, et al. A double-blind, randomized, placebo-controlled, multicenter study of brofaromine in the treatment of posttraumatic stress disorder. Psychopharmacology (Berl) 1995;122:386-389
8. Katz RJ, Lott MH, Arbus P, et al. Pharmacotherapy of post-traumatic stress disorder with a novel psychotropic. Anxiety 1994-1995;1:169-174
9. Baker D, Brady K, Goldstein S, et al. Double-blind flexible dose multicenter study of sertraline and placebo in outpatients with post-traumatic stress disorder [abstract]. Eur Neuropsychopharmacol 1998;8(suppl 2):S261
10. Connor KM, Sutherland SM, Tupler LA, et al. Fluoxetine in post-traumatic stress disorder: randomised, double-blind study. Br J Psychiatry 1999;175: 17-22
11. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988
12. Davidson JRT, Colket JT. The eight-item treatment-outcome post-traumatic stress disorder scale: a brief measure to assess treatment outcome in post-traumatic stress disorder. Int Clin Psychopharmacol 1997;12:41-45
13. van der Kolk BA, Dreyfuss D, Michaels M, et al. Fluoxetine in posttraumatic stress disorder. J Clin Psychiatry 1994;55:517-522
14. Hertzberg MA, Butterfield MI, Feldman ME, et al. A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder. Biol Psychiatry 1999;45:1226-1229
15. Neal LA, Shapland W, Fox C. An open trial of moclobemide in the treatment of post-traumatic stress disorder. Int Clin Psychopharmacol 1997;12: 231-237
16. Malik ML, Connor KM, Sutherland SM, et al. Quality of life and posttraumatic stress disorder: a pilot study assessing changes in SF-36 scores before and after treatment in a placebo-controlled trial of fluoxetine. J Trauma Stress 1999;12:387-393
17. Marshall RD, Schneier FR, Fallon BA, et al. An open trial of paroxetine in patients with noncombat-related, chronic posttraumatic stress disorder. J Clin Psychopharmacol 1998;18:10-18
18. Davidson JRT, Book SW, Colket JT, et al. Assessment of a new self-rating scale for post-traumatic stress disorder. Psychol Med 1997;27:153-160
19. Marmar CR, Schoenfeld F, Weiss DS, et al. Open trial of fluvoxamine treatment for combat-related posttraumatic stress disorder. J Clin Psychiatry 1996;57(suppl 8):66-70
20. Davidson JR, Weisler RH, Malik M, et al. Fluvoxamine in civilians with posttraumatic stress disorder [letter]. J Clin Psychopharmacol 1998;18: 93-95
21. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994
22. Hidalgo R, Hertzberg MA, Mellman T, et al. Nefazodone in post-traumatic stress disorder: results from six open-label trials. Int Clin Psychopharmacol 1999;14:61-68
23. Lipper S, Davidson JRT, Grady TA, et al. Preliminary study of carbamazepine in post-traumatic stress disorder. Psychosomatics 1986;27:849-854
24. Fesler FA. Valproate in combat-related posttraumatic stress disorder. J Clin Psychiatry 1991;52:361-364
25. Beitman BD, Beck NC, Deuser WE, et al. Patient stage of change predicts outcome in a panic disorder medication trial. Anxiety 1994;1:64-69